High response rate with T-VEC in early metastatic melanoma (Stage IIIB/C-IVM1a)

03 medical and health sciences 0302 clinical medicine
DOI: 10.1016/j.ejso.2018.10.461 Publication Date: 2019-01-29T22:22:55Z